Full-Time

Software Engineer in Test 3

Japanese Oncology Portal Application

Posted on 9/20/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$94.3k - $117.9kAnnually

Mid

Remote in USA

Category
Software QA & Testing
Software Engineering
Required Skills
JUnit
SQL
Java
Scala
Selenium
Linux/Unix
Requirements
  • Fluent in Japanese with native-level proficiency, both written and spoken
  • Minimum of 3 years of experience developing test automation frameworks and harnesses using programming and scripting languages.
  • BS degree in Computer Science or equivalent.
  • Strong knowledge of one or more of the following programming languages: Java, Scala
  • Recent hands-on experience with front-end test automation tools and libraries such as Selenium, TestNG, Junit, ScalaTest, Gatling and others.
  • Strong working knowledge of relational databases, strong SQL skills.
  • Strong knowledge of Linux and command line shell scripting.
  • Solid understanding of QA methodologies, test planning, system dependencies, and product integration phases.
Responsibilities
  • Responsible for supporting test infrastructure of Natera software systems and components.
  • Design, build, and maintain data-driven test automation tools and frameworks using clean coding practices and functional programming methodologies.
  • Perform debugging and root cause analysis of product issues or defects.
  • Perform system analysis, assess risk, and develop strong test strategies by analyzing product design and technical specifications, and by collaborating with product managers and developers.
  • Integrate with deployment infrastructure to establish a continuous build and test cycle.
  • Perform test environment set up and configuration.
  • Evangelize new testing methodologies, best practices and tools with goals to continuously improve test coverage through automation.
  • Report, document, and communicate failures discovered through testing with the affected teams.
  • Work closely with developers in all phases of SDLC to build quality into our development process.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera differentiates itself by offering specialized tests like the Signatera ctDNA test and Panorama NIPT for prenatal screening, along with genetic counseling services. The company's goal is to enhance patient care through accurate testing and personalized guidance.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for liquid biopsy techniques boosts Natera's cfDNA testing solutions.
  • Telehealth expansion aligns with Natera's remote genetic counseling services.
  • Growing personalized medicine trend enhances relevance of Natera's ctDNA tests.

What critics are saying

  • Hindenburg report alleges deceptive sales practices, risking legal challenges and reputational damage.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may decline post-RhIg shortage, impacting revenue.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Fetal RhD NIPT test addresses RhIg shortage, offering early fetal RhD status detection.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE